Hidden active information in a random compound library: extraction using a pseudo-structure-activity relationship model.

J Chem Inf Model

Nano Electronics Research Laboratories, Central Research Laboratories, NEC Corporation, 34, Miyukigaoka, Tsukuba, Ibaraki 305-8501, Japan.

Published: March 2008

We propose a hypothesis that "a model of active compound can be provided by integrating information of compounds high-ranked by docking simulation of a random compound library". In our hypothesis, the inclusion of true active compounds in the high-ranked compound is not necessary. We regard the high-ranked compounds as being pseudo-active compounds. As a method to embody our hypothesis, we introduce a pseudo-structure-activity relationship (PSAR) model. Although the PSAR model is the same as a quantitative structure activity relationship (QSAR) model, in terms of statistical methodology, the implications of the training data are different. Known active compounds (ligands) are used as training data in the QSAR model, whereas the pseudo-active compounds are used in the PSAR model. In this study, Random Forest was used as a machine-learning algorithm. From tests for four functionally different targets, estrogen receptor antagonist (ER), thymidine kinase (TK), thrombin, and acetylcholine esterase (AChE), using five scoring functions, we obtained three conclusions: (1) the PSAR models significantly gave higher percentages of known ligands found than random sampling, and these results are sufficient to support our hypothesis; (2) the PSAR models gave higher percentages of known ligands found than normal scoring by scoring function, and these results demonstrate the practical usefulness of the PSAR model; and (3) the PSAR model can assess compounds failed in the docking simulation. Note that PSAR and QSAR models are used in different situations; the advantage of the PSAR model emerges when no ligand is available as training data or when one wants to find novel types of ligands, whereas the QSAR model is effective for finding compounds similar to known ligands when the ligands are already known.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ci7003384DOI Listing

Publication Analysis

Top Keywords

psar model
24
qsar model
12
training data
12
model
11
psar
9
random compound
8
pseudo-structure-activity relationship
8
compounds
8
compounds high-ranked
8
docking simulation
8

Similar Publications

Ultra-high field MRI with parallel transmission (pTx) provides a powerful neuroimaging tool with potential application in paediatrics. The use of pTx, however, necessitates a dedicated local specific absorption rate (SAR) management strategy, able to predict and monitor the peak local SAR (pSAR). In this work, we address the pSARassessment for an in-house built 7 Tesla 16Tx32Rx pediatric head coil, using the concept of Virtual Observation Points (VOPs) for SAR estimation.

View Article and Find Full Text PDF

Aims: This work examines and describes dental health among people seeking asylum and refugees (PSAR) who are evaluated by the Respond service. This includes access to and use of oral health products, access to dental care, and experience of dental pain.

Materials And Methods: The Respond service pilot offered holistic health assessments to PSAR in temporary accommodation within North Central London between July 2021 and March 2023.

View Article and Find Full Text PDF

Correlation of [Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Eur J Nucl Med Mol Imaging

December 2024

Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.

Purpose: to assess the utility of response monitoring to enzalutamide by using [Ga]Ga-PSMA PET in mCRPC patients treated with enzalutamide as first-line therapy.

Methods: patients underwent [Ga]Ga-PSMA PET less than 8 weeks before and 3 months after starting enzalutamide. On the basis of EAU/EANM criteria, patients were categorized as PSMA responders (PET-R) or PSMA non-responders (PET-NR), whilst, based on PSA, they were classified as biochemical responders (PSA-R) or non-responders (PSA-NR).

View Article and Find Full Text PDF

To achieve secure, reliable, and scalable traffic delivery, request streams in mobile Internet of Things (IoT) networks supporting Multi-access Edge Computing (MEC) typically need to pass through a service function chain (SFC) consisting of an ordered series of Virtual Network Functions (VNFs), and then arrive at the target application in the MEC for processing. The high mobility of users and the real-time variability of network traffic in IoT-MEC networks lead to constant changes in the network state, which results in a mismatch between the performance requirements of the currently deployed SFCs and the allocated resources. Meanwhile, there are usually multiple instances of the same VNF in the network, and proactively reconfiguring the deployed SFCs based on the network state changes to ensure high quality of service in the network is a great challenge.

View Article and Find Full Text PDF

Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death.

ACS Appl Mater Interfaces

April 2024

School of Flexible Electronics (Future Technologies) and Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing 211816, China.

Nanomedicine-enhanced immunogenic cell death (ICD) has attracted considerable attention for its great potential in cancer treatment. Even though polyethylene glycol (PEG) is widely recognized as the gold standard for surface modification of nanomedicines, some shortcomings associated with this PEGylation, such as hindered cell endocytosis and accelerated blood clearance phenomenon, have been revealed in recent years. Notably, polysarcosine (PSar) as a highly biocompatible polymer can be finely synthesized by mild ring-opening polymerization (ROP) of sarcosine -carboxyanhydrides (Sar-NCAs) and exhibit great potential as an alternative to PEG.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!